Similarly, EMT and stemness programs are positively associated with DDR1 in renal cell carcinoma (RCC), RB, and glioma, supporting the hypothesis that DDR1-mediated collagen signaling fosters cellular plasticity and therapy resistance. This evidence concerns the gene DDR1 and hereditary clear cell renal cell carcinoma.